Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 113.00
Bid: 111.00
Ask: 115.00
Change: 0.50 (0.44%)
Spread: 4.00 (3.604%)
Open: 112.50
High: 0.00
Low: 0.00
Prev. Close: 112.50
FLO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re offer

10 Jun 2008 08:34

RNS Number : 3455W
Flomerics Group PLC
10 June 2008
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATESAUSTRALIACANADA OR JAPAN

FOR IMMEDIATE RELEASE

10 June 2008

FLOMERICS GROUP PLC

Statement re: Mentor Offer

 

 

The Board of Directors of Flomerics Group PLC ("Flomerics" or the "Company") notes the announcement by Mentor Graphics Inc. (“Mentor”) on 9 June 2008 that as at 3.00pm on that date, the first closing date of the Mentor offer, valid acceptances had been received by Mentor representing only 2.44 per cent of Flomerics' existing issued share capital.

Given the Board's repeated recommendation that Flomerics shareholders should reject the Mentor offer as they believe it materially undervalues Flomerics shares, the Board are pleased to note Mentor have received such a low level of acceptances for its offer. 

Flomerics is a market leader and international brand in growth markets, led by an experienced management team whose focused strategy of investing in people and technology in 2006/7 has started to pay back. Those results are clearly evidenced by the trading statement for the first quarter of 2008, which was published on 27 May 2008, showing Adjusted Revenue up approximately 42% from Q1 2007 and Adjusted Profits up approximately £1.1million from the corresponding quarter of 2007.

The Flomerics Directors confirm that the estimates of Adjusted Revenue and Adjusted Profit reported on in the trading statement remain valid for the purposes of the Mentor offer and that BDO Stoy Hayward LLP and Jefferies International Limited (who reported thereon) have indicated that they have no objection to their reports continuing to apply. 

The Board also reiterates that the discussions with Autodesk, Inc. ("Autodesk"), which were confirmed on 6 June 2008, remain ongoing. Whilst there can be no certainty that an offer from Autodesk will be forthcoming, the Board, which has been so advised by Jefferies International Limited, continues to believe that the Mentor offer is wholly inadequate and therefore recommends shareholders to continue to reject it and take no action in relation to the Mentor offer.

Enquiries: 

 

Flomerics Group PLC

Gary Carter

Keith Butcher

 

Tel: 020 8487 3000

Jefferies International Ltd

Andres Pieczansk

Sarah McNicholas

 

Tel: 020 7029 8000

Oriel Securities Ltd

Andrew Edwards

Michael Shaw

 

Tel: 020 7710 7600

Citigate Dewe Rogerson

Ginny Pulbrook

Seb Hoyle

 

Tel: 020 7638 9571

 

Flomerics Shares in Issue

Pursuant to Rule 2.10 of the City Code, Flomerics confirms that it has 22,935,250 ordinary shares of one penny each in issue and admitted to trading on the Alternative Investment Market of the London Stock Exchange (ISIN GB0003436192).

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the 'Code'), if any person is, or becomes, 'interested' (directly or indirectly) in 1% or more of any class of 'relevant securities' of Flomerics, all 'dealings' in any 'relevant securities' of that company (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the 'offer period' otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Flomerics, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Flomerics by a potential offeror or by Flomerics, or by any of their respective 'associates', must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8, you should consult the Panel.

Other

Jefferies International Limited, which is authorised and regulated in the UK by The Financial Services Authority, is acting exclusively for Flomerics and no one else in connection with the Mentor Offer and, accordingly, will not be responsible to anyone other than Flomerics for providing the protections afforded to customers of Jefferies International Limited or for providing advice in relation to the Mentor Offer or in relation to the contents of this document or any transaction or arrangement or other matter referred to herein.

Oriel Securities Limited ('Oriel Securities'), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Flomerics and no-one else in connection with the matters referred to herein and will not be responsible to anyone other than Flomerics for providing the protections afforded to clients of Oriel Securities or for giving advice in relation to such matters.

If you are in any doubt as to the action you should take in connection with the Mentor Offer, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor, accountant or other independent financial adviser duly authorised under the Financial Services and Markets Act 2000, if you are in the United Kingdom, or, if not, from another appropriately authorised independent financial adviser.

Note to Editors

Flomerics (www.flomerics.com) is a world-leading developer of engineering simulation software and services for analysis of fluid flow, heat transfer. Flomerics' business model is drastically different from traditional analysis because its software is designed to be embedded deeply into the design process and used by mainstream design engineers, not just by analysis specialists.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRFGGMVNGZGRZG
Date   Source Headline
19th Sep 20077:02 amRNSInterim Results
14th Sep 20075:03 pmRNSHolding(s) in Company
15th Aug 20072:27 pmRNSAIM Rule 26
13th Jul 20077:00 amRNSTrading Statement
12th Jul 20075:07 pmRNSHolding(s) in Company
5th Jul 200711:41 amRNSTotal Voting Rights
21st Jun 20075:52 pmRNSAdditional Listing
7th Jun 20072:21 pmRNSAdditional Listing
23rd May 20077:02 amRNSAGM Stmnt and trading update
8th May 200712:40 pmRNSAnnual Report and Accounts
4th May 20075:09 pmRNSDirector/PDMR Shareholding
27th Apr 20079:04 amRNSAdditional Listing
11th Apr 200711:34 amRNSAdditional Listing
27th Mar 20077:02 amRNSFinal Results
15th Mar 200710:56 amRNSNotice of Results
13th Mar 20079:47 amRNSHolding(s) in Company
7th Feb 20078:51 amRNSAdditional Listing
25th Jan 20077:01 amRNSDirectorate Change
11th Jan 20077:32 amRNSTrading Update
22nd Dec 200610:46 amRNSTotal Voting Rights
11th Dec 20066:00 pmRNSAdditional Listing
11th Dec 20065:30 pmRNSDirector/PDMR Shareholding
4th Sep 20065:37 pmRNSDirectorate Change
1st Sep 200612:48 pmRNSAdditional Listing
17th Aug 200612:35 pmRNSDirector/PDMR Shareholding
7th Aug 20067:01 amRNSInterim Results
18th Jul 20064:32 pmRNSNotice of Results
18th Jul 200612:03 pmRNSHolding(s) in Company
12th Jul 200610:10 amRNSHolding(s) in Company
5th Jul 20066:16 pmRNSEGM Statement
15th Jun 20067:10 amRNSAcquisition
9th May 20062:30 pmRNSAdditional Listing
13th Apr 20068:23 amRNSAdditional Listing
30th Mar 20061:47 pmRNSAdditional Listing
30th Mar 200611:15 amRNSHolding(s) in Company
8th Mar 20067:04 amRNSAward of options
23rd Feb 20063:16 pmRNSAdditional Listing
9th Feb 20068:59 amRNSNotice of Results
9th Jan 20067:00 amRNSTrading Statement
25th Nov 20053:38 pmRNSGrant of Options
9th Sep 20054:03 pmRNSBoard Appointment
24th Aug 200512:28 pmRNSAdditional Listing
11th Aug 200512:23 pmRNSFLOTHERM Case Study
27th Jul 20052:32 pmRNSHolding(s) in Company
27th Jul 20057:00 amRNSInterim Results
1st Jul 20058:34 amRNSChange of Adviser
1st Jul 20057:30 amRNSNotice of Results
20th May 20056:07 pmRNSDirectors' Dealing
9th May 20052:49 pmRNSNotifiable Interest
5th May 20055:55 pmRNSNotification of Interest-Amnd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.